OMV AG/ AT0000743059 /
2024-07-26 11:00:16 PM | Chg. +0.360 | Volume | Bid11:00:16 PM | Ask11:00:16 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
39.000EUR | +0.93% | - Turnover: - |
39.000Bid Size: - | 39.080Ask Size: - | 12.7 bill.EUR | 13.00% | 8.58 |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
2021-07-28
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center